Coherus Oncology, Inc.CHRSNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 13.89% |
| Q2 2025 | 26.53% |
| Q1 2025 | -11.36% |
| Q4 2024 | -371.60% |
| Q3 2024 | 15.18% |
| Q2 2024 | -112.09% |
| Q1 2024 | 228.17% |
| Q4 2023 | -73.17% |
| Q3 2023 | 16.33% |
| Q2 2023 | 47.87% |
| Q1 2023 | -10.59% |
| Q4 2022 | 28.57% |
| Q3 2022 | -63.01% |
| Q2 2022 | 49.31% |
| Q1 2022 | -140.00% |
| Q4 2021 | -22.45% |
| Q3 2021 | -22.50% |
| Q2 2021 | 83.12% |
| Q1 2021 | -1923.08% |
| Q4 2020 | -66.67% |
| Q3 2020 | -53.01% |
| Q2 2020 | 66.00% |
| Q1 2020 | -10.71% |
| Q4 2019 | -16.42% |
| Q3 2019 | 97.06% |
| Q2 2019 | 217.24% |
| Q1 2019 | 68.48% |
| Q4 2018 | -5.75% |
| Q3 2018 | -27.94% |
| Q2 2018 | 8.11% |
| Q1 2018 | 11.90% |
| Q4 2017 | 22.94% |
| Q3 2017 | -0.93% |
| Q2 2017 | 29.87% |
| Q1 2017 | 9.94% |
| Q4 2016 | -188.60% |
| Q3 2016 | 212.21% |
| Q2 2016 | -2.99% |
| Q1 2016 | -23.70% |
| Q4 2015 | 27.42% |